0.05Open0.05Pre Close0 Volume394 Open Interest5.00Strike Price0.00Turnover140.79%IV70.03%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1100Delta0.1725Gamma59.40Leverage Ratio-0.0041Theta0.0002Rho6.53Eff Leverage0.0015Vega
ChromaDex Stock Discussion
ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen® Will Debut at Leading Wellness Clinics in August
ChromaDex Corp. (NASDAQ:CDXC) announces the debut of pharmaceutical-grade Niagen® (nicotinamide riboside chloride) for intravenous and injectable use at leading wellness clinics in August. Wells Pharma of Houston, a U.S. FDA-registered 503B outsourcing facility, will compound and distribute Niagen+ to select IV clinics.
Niagen IV offers superior t...
NEWS
ChromaDex’s NIAGEN® (Patented Nicotinamide Riboside, NR), the Most Efficient and High-Quality NAD+ Precursor, Featured in New Solgar® Cellular Nutrition Cellular Energy Supplement
Go go CDXC! 🥳
Nice! Li kaishing very own elixir biomedical company .
$BABA-SW(09988.HK)$ $UOB(U11.SG)$ $CapLand Ascott Trust(HMN.SG)$ $Sembcorp Ind(U96.SG)$ $Yum China(YUMC.US)$ $IFAST(AIY.SG)$ $CKI FIN B2412(05060.HK)$
$Futu Holdings Ltd(FUTU.US)$ $Ginkgo Bioworks(DNA.US)$ $Day One Biopharmaceuticals(DAWN.US)$ $Alibaba(BABA.US)$
300mg — Nicotinamide Riboside | Tru Niagen
$CRISPR Therapeutics(CRSP.US)$ $Ginkgo Bioworks(DNA.US)$ £ $Day One Biopharmaceuticals(DAWN.US)$ $BioNTech(BNTX.US)$ $Moderna(MRNA.US)$
No comment yet